Lisco G, De Tullio A, Iovino M, Disoteo O, Guastamacchia E, Giagulli V
Biomedicines. 2023; 11(11).
PMID: 38001993
PMC: 10669051.
DOI: 10.3390/biomedicines11112993.
Hussain M, Tripathi V
Mil Med Res. 2018; 5(1):11.
PMID: 29598831
PMC: 5877397.
DOI: 10.1186/s40779-018-0158-5.
Han W, Wang T, Chen H
Sci Rep. 2017; 7(1):8052.
PMID: 28808247
PMC: 5556091.
DOI: 10.1038/s41598-017-08291-5.
Zulueta A, Caretti A, Campisi G, Brizzolari A, Abad J, Paroni R
Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(7):753-759.
PMID: 28409208
DOI: 10.1007/s00210-017-1375-2.
Karikari T, Aleksic J
Appl Transl Genom. 2016; 5:3-10.
PMID: 26937352
PMC: 4745356.
DOI: 10.1016/j.atg.2015.06.004.
The media and behavioral genetics: Alternatives coexisting with addiction genetics.
Dingel M, Ostergren J, McCormick J, Hammer R, Koenig B
Sci Technol Human Values. 2015; 40(4):459-486.
PMID: 26392644
PMC: 4574304.
DOI: 10.1177/0162243914558491.
Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns.
Ostergren J, Dingel M, McCormick J, Koenig B
J Health Commun. 2015; 20(5):555-65.
PMID: 25806781
PMC: 4451206.
DOI: 10.1080/10810730.2014.999895.
Challenges in translational research: the views of addiction scientists.
Ostergren J, Hammer R, Dingel M, Koenig B, McCormick J
PLoS One. 2014; 9(4):e93482.
PMID: 24705385
PMC: 3976268.
DOI: 10.1371/journal.pone.0093482.
Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells.
Comer D, Elborn J, Ennis M
BMC Pulm Med. 2014; 14:32.
PMID: 24581246
PMC: 3945717.
DOI: 10.1186/1471-2466-14-32.
Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.
Shields A
Addict Sci Clin Pract. 2011; 6(1):32-43.
PMID: 22003420
PMC: 3188829.
Secondary uses and the governance of de-identified data: lessons from the human genome diversity panel.
Fullerton S, Lee S
BMC Med Ethics. 2011; 12:16.
PMID: 21943371
PMC: 3195203.
DOI: 10.1186/1472-6939-12-16.
'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.
Gundle K, Dingel M, Koenig B
Addiction. 2010; 105(6):974-83.
PMID: 20659058
PMC: 2911634.
DOI: 10.1111/j.1360-0443.2010.02940.x.
Are adolescents with ADHD interested in genetic testing for nicotine addiction susceptibility?.
Herbert L, Walker L, Sharff M, Abraham A, Tercyak K
Int J Environ Res Public Health. 2010; 7(4):1694-707.
PMID: 20617054
PMC: 2872360.
DOI: 10.3390/ijerph7041694.
The global research neglect of unassisted smoking cessation: causes and consequences.
Chapman S, MacKenzie R
PLoS Med. 2010; 7(2):e1000216.
PMID: 20161722
PMC: 2817714.
DOI: 10.1371/journal.pmed.1000216.
Substance use disorder genetic research: investigators and participants grapple with the ethical issues.
Coors M, Raymond K
Psychiatr Genet. 2009; 19(2):83-90.
PMID: 19668113
PMC: 2796541.
DOI: 10.1097/YPG.0b013e328320800e.
Smoking and smoking cessation in disadvantaged women: assessing genetic contributions.
Uhl G, Drgon T, Li C, Johnson C, Liu Q
Drug Alcohol Depend. 2009; 104 Suppl 1:S58-63.
PMID: 19442458
PMC: 9295906.
DOI: 10.1016/j.drugalcdep.2009.03.012.
A research agenda for assessing the potential contribution of genomic medicine to tobacco control.
Hall W
Tob Control. 2007; 16(1):53-8.
PMID: 17297074
PMC: 2598463.
DOI: 10.1136/tc.2006.016303.